Sort by
Refine Your Search
-
Stanford University required minimum for all postdoctoral scholars appointed through the Office of Postdoctoral Affairs. The FY25 minimum is $76,383. Evolution of asymmetric cell division in spiralian
-
Planetary Health (HPH) (link is external) and Project Unleaded (link is external) for an exciting postdoctoral fellowship that contributes to a high-impact global program with a mission to create a
-
Simpson in the School of Engineering and School of Sustainability, Department of Civil and Environmental Engineering at Stanford University. The work will play an important role in the development of a
-
-cell and spatial-omics research. The ideal fellow will be interested in developing and applying novel computational algorithms to novel datasets generated in the setting of non-neoplastic and neoplastic
-
backgrounds trained in chemistry, chemical biology, microbiology, and/or biophysics fields. We have launched a collaborative antibacterial drug design program integrating chemical biology and mechanistic
-
features. Using our recently developed chromosome engineering approach, we have created isogenic stem cell lines that allow us to precisely isolate the effects of the chromosomal abnormality from other
-
to successful community-led conservation, with a particular focus on the role of philanthropic foundations and their grant-making practices. Using a knowledge co-production approach, the project will develop
-
to) the qualifications of the selected candidate, budget availability, and internal equity. Pay Range: $95,000 The Stanford King Center on Global Development’s Postdoctoral Fellows Program offers fellowships
-
University required minimum for all postdoctoral scholars appointed through the Office of Postdoctoral Affairs. The FY25 minimum is $76,383. The Human Brain Development Lab (www.liwanglab.org (link is external
-
laboratory of Stephen Skirboll, MD and Albert Wong, MD, in the Department of Neurosurgery at Stanford University School of Medicine and the VA Palo Alto. We are interested in developing immunotherapies